Silencing of TGF-β in stromal cells co-cultured with FLT3-ITD-AML enhances treatment-induced AML apoptosis and sensitizes AML cells to combination chemotherapy [32]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.